Results 251 to 260 of about 482,975 (382)

Impact of Anticoagulation Therapy on Healthcare Utilization in Patients With Epistaxis. [PDF]

Laryngoscope Investig Otolaryngol
Andersen B, Kadrie A, Chanamolu M, Gillespie MB.   +3 more
europepmc   +1 more source

Anticoagulant effects of Pseudechis australis (Australian king brown snake) venom on human blood: A computerized thromboelastography study

, 1995
Yoswa M. Dambisya, Tat‐Leang Lee, P. Gopalakrishnakone   +2 more
openalex   +2 more sources

National Trends in Ambulatory Oral Anticoagulant Use.

American Journal of Medicine, 2015
G. Barnes, Eleanor Lucas, G. Alexander, Z. Goldberger   +3 more
semanticscholar   +1 more source

Results of the ACCOuNT Trial: A Multi‐Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacogenomics implementation efforts have increased over the last decade, but no published prospective pharmacogenomics trials have formally evaluated utility in underrepresented populations. We present final results from the ACCOuNT trial, a multi‐institutional prospective study [NCT03225820] in which African American inpatients were genotyped and ...
Zhong Huang, Kevin J. O'Leary, Edith A. Nutescu, Matthew Jack, Thomas Chen, Gregory W. Ruhnke, James C. Lee, David George, Larry K. House, Randall Knoebel, Luke V. Rasmussen, Seth Hartman, Anish Choksi, Kiang‐Teck J. Yeo, Minoli A. Perera, Mark J. Ratain, David O. Meltzer, Peter H. O'Donnell   +17 more
wiley   +1 more source

Correction: Prophetic Medicine-Nigella Sativa (Black Cumin Seeds) - Potential Herb for COVID-19?

Journal of Pharmacopuncture, 2020
Naina Mohamed Pakkir Maideen
doaj   +1 more source

Liposomal formulation of <i>Fagonia arabica</i> L. enhances antithrombotic efficacy: phytochemical, pharmacological, and computational investigations. [PDF]

RSC Adv
Badawy SA, Hassan AR, Shafaa MW, Mansour A, Abu Bakr MS, El-Salam I Mohammed A.   +5 more
europepmc   +1 more source

Association of prothrombin complex concentrate administration and hematoma enlargement in non–vitamin K antagonist oral anticoagulant–related intracerebral hemorrhage

Annals of Neurology, 2018
S. Gerner, J. Kuramatsu, J. Sembill, M. Sprügel, M. Endres, K. Haeusler, P. Vajkoczy, P. Ringleb, J. Purrucker, T. Rizos, F. Erbguth, P. Schellinger, G. Fink, H. Stetefeld, H. Schneider, H. Neugebauer, J. Röther, J. Classen, D. Michalski, A. Dörfler, S. Schwab, H. Huttner   +21 more
semanticscholar   +1 more source

Quantitative Model‐Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

Clinical Pharmacology &Therapeutics, EarlyView.
Milvexian, an activated factor XI inhibitor, is being evaluated in the LIBREXIA phase III program for the prevention of thrombotic events, including in patients with atrial fibrillation (LIBREXIA AF). To guide the selection of a phase III dose regimen for LIBREXIA AF, two main approaches were used: (1) population pharmacokinetics and exposure–response ...
Wangda Zhou, Emily Bozenhardt, Gregory E. Alexander, Matthew L. Zierhut, Samira Merali, Antoinette Ajavon‐Hartmann, Peter Zannikos, Hyunmoon Back, EunYoung Suh, Navin Goyal, Mahesh N. Samtani, Alexei N. Plotnikov, Chandni Valiathan   +12 more
wiley   +1 more source

An Unusual Presentation of Antiphospholipid Syndrome With Seizures and Sagittal Sinus Thrombosis: A Case Report. [PDF]

Cureus
Alleelwa B, Faeq MHF, Olaniyi AO.
europepmc   +1 more source

Intracerebral hematomas during anticoagulant treatment. [PDF]

, 1990
C L Franke, Jeroen de Jonge, John C. van Swieten, A A Op de Coul, J. van Gijn   +4 more
openalex   +1 more source